GlassScriptPhysician profile
Hope Starkman
NPI 1144216797
$3,228.38
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $612 · 2021: $1,146 · 2022: $905 · 2023: $245 · 2024: $16.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245 · Education: $16.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.15 |
| Education | $16.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $869.68 | 2020-2022 | |
| Abbvie INC. | $559.83 | 2019-2023 | Skyrizi, Rinvoq, Humira |
| Pfizer INC. | $362.75 | 2019-2023 | |
| Ucb, INC. | $318.56 | 2020-2023 | Cimzia |
| Amgen INC. | $215.81 | 2019-2022 | |
| Radius Health, INC. | $114.39 | 2019-2023 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.08 | 2019-2023 | Ofev |
| Mallinckrodt Enterprises LLC | $92.16 | 2019 | |
| Glaxosmithkline, LLC. | $80.60 | 2020-2022 | |
| Lilly USA, LLC | $77.46 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $71.27 | 2022-2023 | Purified Cortrophin Gel |
| Genentech USA, INC. | $64.50 | 2019 | |
| Mallinckrodt Hospital Products INC. | $44.02 | 2020 | |
| Novartis Pharmaceuticals Corporation | $36.12 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $32.79 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $30.80 | 2023 | |
| Alvogen INC | $29.70 | 2022 | |
| Alexion Pharmaceuticals, INC. | $29.19 | 2021 | |
| Zimmer Biomet Holdings, INC. | $25.19 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.67 | 2020 | |
| Organon LLC | $17.79 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.45 | 2024 | Orencia |
| Fidia Pharma USA INC. | $9.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hope Starkman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.